Blockade of the renin-angiotensin system improves the impaired endothelium-dependent relaxations associated with hypertension and aging, partly through amelioration of endothelium-derived hyperpolarizing factor (EDHF)-mediated responses. Although the nature of EDHF is still controversial, recent studies have suggested the involvement of gap junctions in EDHF-mediated responses. Gap junctions consist of connexins (Cx), and we, therefore, tested whether the expression of Cx in vascular endothelial cells would be altered by hypertension and antihypertensive treatment. Spontaneously hypertensive rats (SHR) were treated with either the angiotensin II type 1 receptor antagonist candesartan or the combination of hydralazine and hydrochlorothiazide for 3 months from 5 to 8 months of age. Confocal laser scanning microscopy after immunofluorescent labeling with antibodies against Cx37, Cx40, and Cx43 revealed that the expression of Cx37 and Cx40 in endothelial cells of the mesenteric artery was significantly lower in SHR than in WKY. Treatment with candesartan, but not the combination of hydralazine and hydrochlorothiazide, significantly increased the expression of Cx37 and Cx40, although blood pressure decreased similarly. On the other hand, the expression of Cx43, though scarce and heterogeneous, was increased in SHR compared with WKY, and candesartan treatment lowered the expression of Cx43.
INTRODUCTION
Endothelial cells play an important role in the regulation of vascular tone by the release of vasoactive factors, such as nitric oxide (15, 33) , prostaglandins, and endothelium-derived hyperpolarizing factor (EDHF) (5, 6) . EDHF relaxes underlying smooth muscle cells through membrane hyperpolarization (5, 13) . Although the nature of EDHF is still debated (1, 2, 3, 9, 12, 29, 47, 48) , several recent studies have suggested the involvement of gap junctions in the EDHF-type response, which may permit the electrical transmission of hyperpolarization from endothelial cells to smooth muscle cells (10, 19, 37) .
The gap junction channel is composed of two hemichannels, named connexons; each connexon comprises 6 subunit proteins called connexins. Three connexins, connexin37 (Cx37), Cx40, and Cx43, have been to be expressed mainly in vascular endothelial cells (20, 35, 49) . These connexins form channels which are suggested to possess different biophysical properties, e.g., conductances, selectivities of passage of small molecular weight substances, and current-carrying ions (41, 45) .
We have previously shown that in the rat mesenteric artery, EDHF-mediated hyperpolarization and relaxation are impaired by hypertension as well as with aging (13, 14) , and that antihypertensive treatments, particularly those using inhibitors of the renin-angiotensin system, improve impaired EDHF-mediated responses (17, 18, 24, 32) . Furthermore, we and others have demonstrated that gap junctions play a critical role in the action of EDHF in this arterial bed (19, 38, 43) . In this context, it is tempting to speculate that connexins, composing gap junctions, would be altered by hypertension H- 00915-2003.R2 Effects of RAS Blockade on Connexins -4 - and drug treatments in the rat mesenteric artery, which might be associated with alterations of the EDHF-mediated responses.
The present study tested whether the expression of connexins in rat vascular endothelial cells would be altered by hypertension and antihypertensive treatment, especially treatment involving inhibitors of the renin-angiotensin system.
MATERIALS and METHODS

Preparation of arteries
This study was approved by the Committee on the Ethics of Animal Experimentation of Kyushu University. Male spontaneously hypertensive rats (SHR) and age-matched Wistar-Kyoto rats (WKY) were fed a standard rat chow and had free access to tap water.
At the age of 5 months, SHR were assigned to one control (SHR-CON) and to one of two treatment groups. The latter two groups were treated for 3 months with either the AT1 receptor antagonist candesartan cilexetil (5 mg/kg/day, SHR-CAN) or the combination of hydralazine and hydrochlorothiazide (25 mg/kg/day and 7.5 mg/kg/day, respectively, SHR-HH), from 5 to 8 months of age. All drugs were given in the drinking water. Water intake was checked three times a week, and drug concentrations were adjusted to achieve the above daily doses. Age-matched, untreated WKY (WKY-CON) served as controls (n=4-6 in each group). In addition, in some studies, 15-week-old, young SHR (SHR-Y) and WKY (WKY-Y) also served as young controls (n=5 in each group).
Systolic blood pressure was measured in conscious rats before and at the end of the treatment period. The drugs were withdrawn 2 days before the experiments. The rats were deeply anesthetized with ether and killed by decapitation. The main trunk (elastic arteries) and the second or third branches (muscular arteries) of the mesenteric H-00915-2003.R2
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-5 -artery were excised, and heparin (600 U in 300 µL) in phosphate-buffered saline (PBS) was injected into the mesenteric artery to prevent clotting. The artery was cut into rings of 2 mm in length in PBS for use in the confocal laser scanning microscopy experiment with immunofluorescence.
Immunohistochemistry
The arteries were cut along the longitudinal axis for whole-mount preparation.
Whole-mount samples were fixed in acetone at -20°C for an hour. After brief washing with PBS, the samples were incubated in a blocking solution (PBS containing 1% non-fat dry milk and 0.5% Triton X-100) for an hour at room temperature. Samples were exposed to either Cx37 (affinity-purified rabbit anti-Cx37, Alpha Diagnostic International Inc.: dilution 1:1000), Cx40 (affinity-purified rabbit anti-Cx40, Chemicon International Inc.: dilution 1:1000), or Cx43 antibodies (affinity-purified rabbit anti-Cx43, Zymed Laboratories, Inc.: dilution 1:1000) at 4°C overnight (20, 30, 31) .
After washing in PBS for an hour, the samples were incubated with secondary antibodies (Alexa488-conjugated goat anti-rabbit IgG antibodies, Molecular Probes, Inc.; dilution 1:500) for 2 hours. For negative control, primary antibodies were omitted. After washing in PBS, the samples were mounted with the endothelial layer up in the mounting medium VECTASHIELD containing propidium iodide (Vector Laboratories, Inc.) for counterstaining nuclei. Samples were observed using a Zeiss LSM310 confocal laser scanning microscope. The number of immunolabeled connexin plaques per endothelial cell was determined from ten cells in each animal. 
Statistical Analysis
Results are given as mean±SEM. Data were analyzed by one-way ANOVA followed by the Scheffé test for multiple comparisons or paired Student's t test, if appropriate. A level of P<0.05 was considered statistically significant.
RESULTS
Systolic Blood Pressure, Heart Rate, and Body Weight
The systolic blood pressure, heart rates, and body weights of WKY and SHR before and at the end of the treatment period are shown in Table. Chronic treatment with candesartan cilexetil and the combination of hydralazine and hydrochlorothiazide lowered the blood pressure to comparable extents.
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Connexin expression
First, the distribution of Cxs was investigated in cross sectional sections of the elastic and muscular arteries from the rat mesenteric arterial bed. In the elastic arteries of normotensive WKY rats, Cx37 was found both in the endothelium and the media.
Cx40 was expressed in the endothelium, but not in the media. Small expression of Cx43 was observed in the media only. In the muscular arteries of WKY, both Cx37 and Cx40 existed abundantly in the endothelium. Cx43 was not observed in these arteries. Because quantitative analysis of Cxs was difficult in cross sectional preparations, we focused on the expression of Cxs on endothelial cells using whole-mount preparations in the following experiments.
In investigating the expression of these Cxs on the endothelial cells with whole-mount preparations, the side opposite branching was chosen for the experiment regarding the main trunk of the mesenteric arteries because this side provides a continuous population of endothelial cells probably due to the minimal effect of flow stress in this region. In the branching side of the arteries, endothelial cells showed irregular and changed shapes especially near the branching region.
In the main trunk of the mesenteric artery, the number of Cx37 and Cx40 plaques per endothelial cell was significantly decreased in SHR-CON compared with WKY-CON ( Figs 
DISCUSSION
The present study demonstrated that the expression of Cx37 and Cx40 was significantly decreased in vascular endothelial cells from SHR compared with WKY. Chronic treatment with the angiotensin II type 1 receptor antagonist candesartan, but not the traditional combination of hydralazine and hydrochlorothiazide, led to a significant increase in the expression of Cx37 and Cx40 in endothelial cells, although blood pressure was reduced similarly by both treatments. The expression of Cx43 was relatively difficult to evaluate because of scarce and heterogeneous distribution; however, the expression of Cx43 appeared to be increased in SHR compared with WKY, and treatment with candesartan lowered Cx43 expression. These findings suggest that the inhibition of the renin-angiotensin system restores the decreased expression of Cx37 and Cx40 in the vascular endothelial cells of hypertensive rats, whereas Cx43 appears to exhibit changes in the opposite direction.
In the endothelial cells of the rat large and small mesenteric arteries, Cx40 was most abundantly expressed, followed by Cx37. Cx43 was only scarcely observed in the endothelial cells of normotensive rats. In the media, small expression of Cx37 and Cx43, but not of Cx40, was observed. Although Cx45 has also been identified in certain vascular tissues (26, 27) , we could not detect expression of Cx45 in the endothelial cells of the rat mesenteric artery (data not shown), which is consistent with some other studies (25, 36) . The specificity of antibodies against Cx37, Cx40 and Cx43 used in this study has been confirmed in the previous studies from our and other laboratories (20, 30, 31) . Using the same antibodies as used in this study, Gustafsson et H-00915-2003 .R2
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-11 -al. (20) have confirmed specific stainings for Cx37, Cx40 and Cx43 for corresponding antibodies in the rat mesenteric vascular bed (20) .
Several recent studies, including those on the rat mesenteric arteries, suggest that gap junctions play an important role in EDHF-mediated responses (19, 37, 38, 43) . It is assumed that hyperpolarization or small molecules generated in endothelial cells may spread to underlying smooth muscle cells via the myoendothelial gap junction (4, 37, 38, 44, 47) . The relative importance of EDHF to relaxation and the spatial distribution of gap junctions appear to coincide; i.e., EDHF has been shown to play a more important role in small arteries than in large arteries, and the incidence of myoendothelial gap junctions, determined by electron microscopy, is higher in small mesenteric arteries than in large mesenteric arteries, findings being suggestive of the role of gap junctions in EDHF-mediated responses (37) . In this study, the expression of Cx37 and Cx40 was also higher in small mesenteric arteries (muscular arteries) than in large mesenteric arterial trunks (elastic arteries), implying the greater involvement of gap junctional communication in smaller arteries, although such Cxs expression may represent mainly those between endothelial cells.
We have previously demonstrated that EDHF-mediated hyperpolarization and relaxation are impaired by hypertension and with aging (13, 14) . We also found that antihypertensive treatment improves the impairment of EDHF-mediated responses associated with hypertension and aging (17, 18, 24, 32) . The direction of changes of the expression of Cx37 and Cx40 in the present study, i.e., a decrease in hypertension and with aging and an increase with antihypertensive treatment, especially with that including the AT1 receptor antagonist, appeared to coincide with changes in the EDHF-mediated responses in our previous studies. Furthermore, differences in the expression of Cx37 and 40 between SHR and WKY appeared to be greater in older rats H-00915-2003.R2
-12 -than in younger rats, suggesting that the expression of these connexins is down-regulated during the course of hypertension. In addition, the expression of Cx37 tended to decrease with aging even in normotensive rats. On the other hand, the expression of Cx43 increased in hypertension and with aging, and decreased with the AT1 receptor antagonist, changes opposite to those in EDHF-mediated responses.
It is at present unclear which connexins are involved mainly in the EDHF-type responses. Furthermore, three types of heterocellular couplings via gap junctions exist and each might contribute to EDHF-mediated responses in blood vessels, namely those between endothelial cells, smooth muscle cells, and endothelial and smooth muscle cells.
In fact, the combination of gap junction inhibitors targeted to each of these connexins, Cx37, Cx40, and Cx43, was required to abolish the EDHF-mediated relaxation in the rat hepatic artery (4) . It has also been demonstrated that electrical signals in the vessel wall may travel quite effectively in the longitudinal direction primarily through endothelial cells via gap junctions, indicating the importance of the gap junction between endothelial cells (11, 40, 48) . Theoretically, the impairment of EDHF responses could be accounted for by a defect in any of these three gap junction pathways. The expression of connexins observed in this study may represent mainly those between endothelial cells. Providing that homocellular, as well as heterocellular, gap junctions play a role in EDHF-mediated responses in the rat mesenteric arteries, it is possible to speculate that a decrease in the expression of Cx37 and Cx40 between endothelial cells might lead to an impaired conduction between endothelial cells, resulting in an overall reduction in the EDHF-type response. Indeed, conduction of vasodilation along arterioles was severely attenuated in mice deficient of Cx40 (7) . Alternatively, some of extend their study by showing for the first time that the inhibitor of the renin-angiotensin system by the angiotensin II receptor antagonist candesartan corrects the decreased expression of these Cxs. Such an effect of candesartan is likely to be in part due to the inhibition of the renin-angiotensin system per se rather that to its blood pressure lowering effect alone, since the traditional combination of hydralazine and hydrochlorothiazide only partially increased the expression of Cx37 and Cx40 despite achieving a similar reduction in blood pressure. This is also consistent with our previous study concerning the effect of drug treatment on EDHF-mediated response; i.e., a more marked improvement of EDHF-mediated responses was observed in association with the inhibitors of renin-angiotensin system than with other classes of antihypertensive agents. It remains to be determined whether the renin-angiotensin system and its inhibition directly influence the expression of Cx37 and Cx40 in vascular walls or indirectly through correction of vascular remodelings (39) .
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In the present study, Cx43 increased by hypertension and decreased by antihypertensive treatment, especially with candesartan. In fact, the regulation of Cx43 appeared to differ from those of Cx37 and Cx40 (8, 16, 23, 34) .; e.g., in cardiac cells, it has been demonstrated that the expression of Cx43 and Cx40 is differentially regulated (8) . Gabriels et al. suggested that Cx43, unlike Cx37 and Cx40, localized to regions that experience turbulent shear stress from disturbed blood flow in endothelial cells of the rat aorta (16) . It is, therefore, possible to speculate that endothelial Cx43 expression might increase due to turbulent shear stress and higher shear stress in hypertension and decrease by antihypertensive treatment. Consistent with our findings, Cx43 expression was increased in tissue homogenized from aortas of mineralocorticoid-salt hypertension and renal artery clip hypertension rats (21, 46) . On the other hand, in the study by Rummery, Cx43 was decreased in endothelial cells from SHR compared with WKY, although to a lesser extent compared with Cx37 and Cx40.
A decrease in Cx43 m RNA expression was also reported in the aorta of rats treated with N G -nitro-L-arginine methyl ester (22) .
It appears, therefore, that the expression of Cx43 in the vascular wall may differ depending on the type of hypertension, vascular beds, and/or cell types (i.e., endothelial cells or smooth muscle cells). Interestingly, endothelial cell-specific knockout of Cx43 has been shown to cause hypotension in mice (28) , although overall role of Cx43 in the regulation of vascular tone requires further investigation.
There are some reports suggesting a possible link between AT1 receptor activation and Cx43 expression. In cultured rat cardiac cells, angiotensin II has been shown to increase Cx43 but not Cx40 expression through AT1 receptors, which involves the signal transduction pathways, including extracellular signal-regulated kinase 1/2 (ERK 1/2) and p38 (34) . It has also been shown that cyclical mechanical stretch increases H-00915-2003.R2 -15 - angiotensin II production and Cx43 gene expression in cultured rat cardiomyocytes, partially through AT1 receptors (42) . These in vitro findings obtained in cardiac cells suggest possible association between mechanical stress, angiotensin II and Cx43 expression. It remains to be determined whether angiotensin II exhibits similar effects on Cx43 expression in vascular endothelial cells. In any case, the present study for the first time revealed the possibility that chronic in vivo blockade of the renin-angiotensin system could modulate endothelial cell connexin expression, either positively (in the case of Cx37 and Cx40) or negatively (Cx43).
In conclusion, the present study has demonstrated that the expression of Cx37 and Cx40 in endothelial cells from the mesenteric arteries was decreased in hypertensive rats, and the treatment with AT1 receptor antagonist increased the expression of Cx37 and 
